<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00066144</url>
  </required_header>
  <id_info>
    <org_study_id>P50AT000155</org_study_id>
    <nct_id>NCT00066144</nct_id>
  </id_info>
  <brief_title>Use of Black Cohosh and Red Clover for the Relief of Menopausal Symptoms</brief_title>
  <official_title>Black Cohosh and Red Clover Efficacy for the Relief of Menopausal Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Center for Complementary and Integrative Health (NCCIH)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Office of Dietary Supplements (ODS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>National Center for Complementary and Integrative Health (NCCIH)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This Phase II study, a follow-up to a Phase I trial in normal volunteers, will determine the
      efficacy of black cohosh and red clover for the relief of menopausal symptoms. It will also
      assess the safety of chronic dosing (1 year) by evaluating uterine (endometrial biopsies),
      breast (mammography), and hematology parameters (CBC and chemistry lab values) at baseline
      and 1 year.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">April 2006</completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment type="Anticipated">112</enrollment>
  <condition>Hot Flashes</condition>
  <condition>Menopause</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cimicifuga racemosa</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Trifolium pratense</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Black cohosh</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Red clover</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Menopausal women with intact uterus

          -  Must be experiencing hot flashes

          -  No menstrual periods for at least 6 months and no longer than 3 years

          -  Non-smoker

          -  Must have intact uterus (no hysterectomy)

        Exclusion Criteria:

          -  Contraindications for hormone replacement therapy

          -  Diabetes mellitus

          -  Pregnancy or breast-feeding

          -  Obese (BMI &gt;35 excluded)

          -  History of endometrial hyperplasia/neoplasia/malignancy

          -  History of breast or reproductive cancer

          -  History of severe recurrent depression, or severe psychiatric disturbance

          -  History of stroke/CVA, severe varicose veins, sickle cell anemia, myocardial
             infarction (heart attack), or arrhythmia (rhythm disturbance of the heart)

          -  History of abnormal vaginal bleeding of unknown cause

          -  Untreated or uncontrolled high blood pressure/hypertension

          -  Use of any medication or supplement containing estrogen, progestin, SERM, St. John's
             Wort, bisphosphonates, or phytoestrogens

          -  History of hormone-associated migraines

          -  History of deep vein thrombosis (blood clots), thrombophlebitis, or thromboembolic
             disorders

          -  Participation in a clinical trial within 30 days

          -  Abnormal endometrial biopsy or mammogram

          -  Abnormal transvaginal ultrasound defined as &gt;7mm thickness

          -  Vegan
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stacie Geller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Obstetrics and Gynecology University of Illinois, Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Illinois at Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2003</study_first_submitted>
  <study_first_submitted_qc>August 4, 2003</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2003</study_first_posted>
  <last_update_submitted>October 11, 2007</last_update_submitted>
  <last_update_submitted_qc>October 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2007</last_update_posted>
  <keyword>menopause</keyword>
  <keyword>hot flashes</keyword>
  <keyword>red clover</keyword>
  <keyword>black cohosh</keyword>
  <keyword>sexual dysfunction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

